Correlation Between Milestone Pharmaceuticals and Aditxt
Can any of the company-specific risk be diversified away by investing in both Milestone Pharmaceuticals and Aditxt at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Milestone Pharmaceuticals and Aditxt into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Milestone Pharmaceuticals and Aditxt Inc, you can compare the effects of market volatilities on Milestone Pharmaceuticals and Aditxt and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Milestone Pharmaceuticals with a short position of Aditxt. Check out your portfolio center. Please also check ongoing floating volatility patterns of Milestone Pharmaceuticals and Aditxt.
Diversification Opportunities for Milestone Pharmaceuticals and Aditxt
-0.39 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Milestone and Aditxt is -0.39. Overlapping area represents the amount of risk that can be diversified away by holding Milestone Pharmaceuticals and Aditxt Inc in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Aditxt Inc and Milestone Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Milestone Pharmaceuticals are associated (or correlated) with Aditxt. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Aditxt Inc has no effect on the direction of Milestone Pharmaceuticals i.e., Milestone Pharmaceuticals and Aditxt go up and down completely randomly.
Pair Corralation between Milestone Pharmaceuticals and Aditxt
Given the investment horizon of 90 days Milestone Pharmaceuticals is expected to generate 0.46 times more return on investment than Aditxt. However, Milestone Pharmaceuticals is 2.19 times less risky than Aditxt. It trades about -0.01 of its potential returns per unit of risk. Aditxt Inc is currently generating about -0.2 per unit of risk. If you would invest 283.00 in Milestone Pharmaceuticals on August 24, 2024 and sell it today you would lose (98.00) from holding Milestone Pharmaceuticals or give up 34.63% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Milestone Pharmaceuticals vs. Aditxt Inc
Performance |
| Timeline |
| Milestone Pharmaceuticals |
| Aditxt Inc |
Milestone Pharmaceuticals and Aditxt Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Milestone Pharmaceuticals and Aditxt
The main advantage of trading using opposite Milestone Pharmaceuticals and Aditxt positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Milestone Pharmaceuticals position performs unexpectedly, Aditxt can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Aditxt will offset losses from the drop in Aditxt's long position.The idea behind Milestone Pharmaceuticals and Aditxt Inc pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
| Aditxt vs. Neurobo Pharmaceuticals | Aditxt vs. Dermata Therapeutics | Aditxt vs. Unicycive Therapeutics | Aditxt vs. Revelation Biosciences |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Search module to search for actively traded equities including funds and ETFs from over 30 global markets.
Other Complementary Tools
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios |